Certain Balance Sheet Items

3 Months Ended

Mar. 31, 2026

Property, plant and equipment consisted of the following (in millions):


	March 31, 2026		December 31, 2025
Manufacturing equipment and machinery	$	92.9	$	97.4
Land and buildings	71.8		72.2
Computer software	63.5		63.7
Leasehold improvements	63.6		63.6
Construction-in-progress	60.1		49.6
Computer equipment	22.5		21.9
Furniture and fixtures	10.4		10.0

Subtotal	384.8		378.4
Less accumulated depreciation and amortization	(181.7)		(178.5)
Property, plant and equipment, net	$	203.1	$	199.9

Accrued liabilities consisted of the following (in millions):


	March 31, 2026		December 31, 2025
Rebates and other sales deductions	$	484.3	$	459.8
Employee compensation and benefits	182.2		215.4

Inventory-related accruals	57.3		34.0
Accrued royalties	47.6		47.1
Clinical trial accruals	38.2		42.0
Sales return reserve	26.6		26.4
Consulting and professional services	22.2		23.0
Accrued development expenses	21.6		24.4
Accrued interest	21.4		40.7
Selling and marketing accruals	21.4		15.4

Current portion of lease liabilities	14.9		14.7
Accrued construction-in-progress	9.6		14.3
Derivative instrument liabilities	8.5		4.2



Other	66.6		72.8
Total accrued liabilities	$	1,022.4	$	1,034.2

Jazz Pharmaceuticals plc 10-Q